Article
Construction of 5-aminolevulinic acid synthase variants by cysteine-targeted mutation to release heme inhibition.
Journal of bioscience and bioengineering - 1 Nov 2022
He Guimei, Jiang Meiru, Cui Zhenzhen, Sun Xi, Chen Tao, Wang Zhiwen
Abstract excerpt
5-Aminolevulinic acid (5-ALA), a vital precursor for the biosynthesis of tetrapyrrole compounds, has been widely applied in agriculture and medicine, while extremely potential for the treatment of cancers, corona virus disease 2019 (COVID-19) and metabolic diseases in recent years. With the development of metabolic engineering and synthetic biology, the biosynthesis of 5-ALA has attracted increasing attention....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
